Does Central Nervous System Depressants Interact with Olopatadine Hydrochloride And Mometasone Furoate?
Central Nervous System Depressants and Olopatadine Hydrochloride And Mometasone Furoate have a moderate drug interaction according to U.S. FDA drug labeling data. Concurrent use with CNS depressants should be avoided due to risk of somnolence and impairment of CNS performance. The mechanism involves additive central nervous system depression. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Moderate
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Central Nervous System Depressants and Olopatadine Hydrochloride And Mometasone Furoate occurs because additive central nervous system depression. Clinically, this means concurrent use with cns depressants should be avoided due to risk of somnolence and impairment of cns performance. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.
What To Tell Your Doctor or Pharmacist
If you are taking Central Nervous System Depressants and your doctor is considering prescribing Olopatadine Hydrochloride And Mometasone Furoate (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider